Announcements Trials
Browse Landscape

Status

Completed 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Gastrointestinal 1

Conditions

Hepatitis B 2Carcinoma, Hepatocellular 2Liver Failure, Acute 1Leukemia, Lymphocytic, Chronic, B-Cell 1Fibrosis 1

Interventions

Lamivudine 2hepatitis B hyperimmune globulin 1entecavir 1bicyclol 1adefovir dipivoxil 1Urinalysis 1Tablets 1Radiomics 1Radiofrequency Ablation 1Pharmaceutical Preparations 1Nucleosides 1Interferons 1Acids 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Hepatitis B × Lamivudine × Clear all
NCT00059267 2024-11-15

Prevention of Recurrent Hepatitis B After Liver Transplantation

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed
317 enrolled
Gastrointestinal

Fibrosis, Hepatitis B, Carcinoma, Hepatocellular, Liver Failure, Acute

NCT03528941 2022-05-12

LLC1618

Gruppo Italiano Malattie EMatologiche dell'Adulto

Completed
109 enrolled
LymphoidOther hematologic neoplasm

Hepatitis B, Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡